Epidemiology of drug resistance: implications for a post-antimicrobial era

M L Cohen1

  • 1Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases, Centers for Disease Control, Atlanta, GA 30333.

Science (New York, N.Y.)
|August 21, 1992
PubMed

Insights

Antimicrobial resistance is rising globally, leading to untreatable infections and increased healthcare costs. Combating this requires new drugs, vaccines, and better public health strategies to curb transmission.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Public Health

Background:

  • Rising frequency and spectrum of antimicrobial-resistant infections in hospital and community settings.
  • Emergence of untreatable infections as epidemics globally and in the United States.
  • Attribution of increasing drug resistance to microbial traits, antimicrobial use, and transmission factors.

Purpose of the Study:

  • To summarize the current state of antimicrobial resistance.
  • To identify contributing factors to the rise in drug-resistant infections.
  • To outline necessary strategies for prevention and control.

Main Methods:

  • Literature review and synthesis of current data on antimicrobial resistance.
  • Analysis of factors contributing to the spread of resistant organisms.
  • Identification of key areas for intervention.

Main Results:

  • Significant increase in antimicrobial-resistant infections.
  • Untreatable infections are becoming epidemic.
  • Antimicrobial resistance leads to higher morbidity, mortality, and healthcare expenses.

Conclusions:

  • Urgent need for new antimicrobial agents and vaccines.
  • Prudent use of existing antimicrobials is critical.
  • Enhanced public health measures are essential to reduce transmission and control resistance.

Related Concept Videos

Pharmacokinetic–Pharmacodynamic Relationship: Influence of Elimination Half-Life on Effect Duration01:23

Pharmacokinetic–Pharmacodynamic Relationship: Influence of Elimination Half-Life on Effect Duration

Drug elimination from the body primarily occurs through metabolic and excretion pathways. Hepatic metabolism transforms lipophilic drugs into hydrophilic forms for excretion, typically via enzymatic processes classified as phase I (modification) and phase II (conjugation). Renal excretion eliminates drugs and metabolites through filtration and secretion in the kidneys. Impairment in liver or kidney function can hinder these processes, delaying drug clearance and extending the drug’s half-life.
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Microbiota Modulation by Antibiotics01:21

Microbiota Modulation by Antibiotics

Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...